Editorial
doi: 10.1056/NEJMe1902214.
Epub 2019 Mar 17.
Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI
Affiliations
- PMID: 30883051
- DOI: 10.1056/NEJMe1902214
Item in Clipboard
Editorial
Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI
N Engl J Med.
.
No abstract available
Comment on
-
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17. N Engl J Med. 2019. PMID: 30883055 Clinical Trial.
Similar articles
-
What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?Cleve Clin J Med. 2021 Jul 1;88(7):389-392. doi: 10.3949/ccjm.88a.19081. Cleve Clin J Med. 2021. PMID: 34210713 No abstract available.
-
The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation.Eur J Intern Med. 2021 Jun;88:21-22. doi: 10.1016/j.ejim.2021.04.008. Epub 2021 Apr 30. Eur J Intern Med. 2021. PMID: 33934970 No abstract available.
-
Antithrombotic therapy for patients with chronic coronary syndromes.Heart. 2021 Jun;107(11):925-933. doi: 10.1136/heartjnl-2020-316914. Epub 2020 Oct 30. Heart. 2021. PMID: 33127651 Review. No abstract available.
-
Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.Cardiovasc Drugs Ther. 2018 Apr;32(2):191-196. doi: 10.1007/s10557-018-6789-7. Cardiovasc Drugs Ther. 2018. PMID: 29679301
-
Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006. Can J Cardiol. 2013. PMID: 23790600 Review.
Cited by
-
Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study.Front Pharmacol. 2023 Feb 2;14:1088900. doi: 10.3389/fphar.2023.1088900. eCollection 2023. Front Pharmacol. 2023. PMID: 36817138 Free PMC article.
-
A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial.EuroIntervention. 2022 Jul 22;18(4):e292-e302. doi: 10.4244/EIJ-D-21-00165. EuroIntervention. 2022. PMID: 35105533 Free PMC article.
-
Carotid Artery Stenting in Patients with Atrial Fibrillation: Direct Oral Anticoagulants, Brief Double Antiplatelets, and Testing Strategy.J Clin Med. 2021 Nov 11;10(22):5242. doi: 10.3390/jcm10225242. J Clin Med. 2021. PMID: 34830524 Free PMC article.
-
Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis.Aging (Albany NY). 2020 Jul 1;12(13):12930-12942. doi: 10.18632/aging.103359. Epub 2020 Jul 1. Aging (Albany NY). 2020. PMID: 32611835 Free PMC article.
-
Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.Am J Cardiovasc Drugs. 2021 Jan;21(1):11-20. doi: 10.1007/s40256-020-00403-3. Am J Cardiovasc Drugs. 2021. PMID: 32170515 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
